91 related articles for article (PubMed ID: 23729020)
41. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
42. Differential prognostic impact of comorbidity in head and neck cancer.
Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
[TBL] [Abstract][Full Text] [Related]
43. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
44. Juvenile malignant melanoma of the head and neck.
Fisher SR; Reintgen DS; Seigler HF
Laryngoscope; 1988 Feb; 98(2):184-9. PubMed ID: 3339930
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
46. Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 an 1999.
Dunphy FR; Dunleavy TL; Harrison BR; Trinkaus KM; Kim HJ; Stack BC; Needles B; Boyd JH
Cancer; 2001 Mar; 91(5):940-8. PubMed ID: 11251945
[TBL] [Abstract][Full Text] [Related]
47. Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study.
Huang SH; O'Sullivan B; Waldron J; Lockwood G; Bayley A; Kim J; Cummings B; Dawson LA; Hope A; Cho J; Witterick I; Chen EX; Ringash J
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):46-51. PubMed ID: 20395066
[TBL] [Abstract][Full Text] [Related]
48. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary?
Clark JR; Veness MJ; Gilbert R; O'Brien CJ; Gullane PJ
Head Neck; 2007 Mar; 29(3):249-57. PubMed ID: 17163472
[TBL] [Abstract][Full Text] [Related]
49. Initial clinical findings of a mathematical model to predict survival of head and neck cancer.
Emerick KS; Leavitt ER; Michaelson JS; Diephuis B; Clark JR; Deschler DG
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):572-8. PubMed ID: 23797612
[TBL] [Abstract][Full Text] [Related]
50. Clinical outcome of head and neck cancer patients: a comparison between ENT patients referred via the 2 weeks wait pathway and alternative routes in the UK health system.
Wong BYW; Fischer S; Cruickshank HE
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):415-420. PubMed ID: 27416743
[TBL] [Abstract][Full Text] [Related]
51. Optimizing perioperative management of geriatric patients with head and neck cancer.
Shuman AG; Patel SG; Shah JP; Korc-Grodzicki B
Head Neck; 2014 May; 36(5):743-9. PubMed ID: 23596001
[TBL] [Abstract][Full Text] [Related]
52. Clinical ethics consultation in patients with head and neck cancer.
Shuman AG; McCabe MS; Fins JJ; Kraus DH; Shah JP; Patel SG
Head Neck; 2013 Nov; 35(11):1647-51. PubMed ID: 23161591
[TBL] [Abstract][Full Text] [Related]
53. Co-morbidity and treatment outcomes of elderly pharyngeal cancer patients: a matched control study.
Peters TT; Langendijk JA; Plaat BE; Wedman J; Roodenburg JL; van Dijk BA; Sluiter WJ; van der Laan BF; Halmos GB
Oral Oncol; 2011 Dec; 47(12):1159-64. PubMed ID: 21885328
[TBL] [Abstract][Full Text] [Related]
54. A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer Center.
Budde MK; Kuhn W; Keyver-Paik MD; Bootz F; Kalff JC; Müller SC; Bieber T; Brossart P; Vatter H; Herrlinger U; Wirtz DC; Schild HH; Kristiansen G; Pietsch T; Aretz S; Geiser F; Radbruch L; Reich RH; Strassburg CP; Skowasch D; Essler M; Ernstmann N; Landsberg J; Funke B; Schmidt-Wolf IGH
BMC Cancer; 2019 Oct; 19(1):1024. PubMed ID: 31666035
[TBL] [Abstract][Full Text] [Related]
55. Limitations of surgery in the treatment of head and neck cancer.
Stell PM
Can J Otolaryngol; 1975; 4(3):508-12. PubMed ID: 1182604
[TBL] [Abstract][Full Text] [Related]
56. Dispositional optimism predicts survival status 1 year after diagnosis in head and neck cancer patients.
Allison PJ; Guichard C; Fung K; Gilain L
J Clin Oncol; 2003 Feb; 21(3):543-8. PubMed ID: 12560447
[TBL] [Abstract][Full Text] [Related]
57. Management of head and neck cancer in older patients.
Magnano M; Bertone F; Andreis M; Boffano P; Machetta G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Apr; 125(4):369-375. PubMed ID: 29501356
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors of survival in a cohort of head and neck cancer patients in Oslo.
Faye-Lund H; Abdelnoor M
Eur J Cancer B Oral Oncol; 1996 Mar; 32B(2):83-90. PubMed ID: 8736169
[TBL] [Abstract][Full Text] [Related]
59. Presenting symptoms and long-term survival in head and neck cancer.
Douglas CM; Ingarfield K; McMahon AD; Savage SA; Conway DI; MacKenzie K
Clin Otolaryngol; 2018 Jun; 43(3):795-804. PubMed ID: 29247495
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Time to Surgery and Its Effect on Prognosis in Head and Neck Cancer.
Tham T; Leung E; Khaymovich J; Mitha S; Olson C; Wotman M; Teegala S; Coury J; Costantino P
Oncol Res Treat; 2019; 42(7-8):387-395. PubMed ID: 31079104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
